Open to tie-ups in India for selling Mounjaro: Eli Lilly CEO David Ricks

Eli Lilly is exploring partnerships with Indian pharma firms to market its anti-diabetes and weight loss drug Mounjaro, recently launched in India. Priced significantly lower than in the US, Mounjaro's introduction anticipates strong demand in the country with over 100 million obese and diabetic individuals.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/rW20Y4f
via IFTTT